Welcome to Blood Cancer United Newsroom
Get the latest news about how we are creating a world without blood cancers—and improving the quality of life of patients and their families.
News
World Renowned Childhood Blood Cancer Expert Named as The Leukemia & Lymphoma Society's New President and CEO
The Leukemia & Lymphoma Society (LLS), the global leader and innovator in creating a world without blood cancer, is proud to announce E. Anders Kolb, …
News
FDA Approves New Formulation of Important Childhood Leukemia Drug
The U.S. Food and Drug Administration yesterday approved nelarabine injection, a critical treatment for T-cell acute lymphoblastic leukemia (T-ALL), a…
Research
Faron Announces Results of Placing, Including Additional Investment by The Leukemia & Lymphoma Society Therapy Acceleration Program®
TURKU, FINLAND / BOSTON, MA - January 27 2023 - Faron Pharmaceuticals Ltd (First North: FARON, AIM: FARN), a clinical stage biopharmaceutical company …
News
Sharing Decades of a Dedicated Vision to End Cancer
Sharing Decades of a Dedicated Vision to End Cancer
News
FDA Approves New Type of BTK Inhibitor to Treat Mantle Cell Lymphoma
The U.S. Food and Drug Administration today approved pirtobrutinib (Jaypirca™), the first non-covalent, reversable BTK inhibitor for the treatment of …
Research
Encouraging Additional Data for Bexmarilimab for the Treatment of Hematological Malignancies
January 16, 2023 - TURKU, FINLAND / BOSTON, MA - Faron Pharmaceuticals Oy (AIM: FARN, First North: FARON), a clinical stage biopharmaceutical company …
Research
BioInvent Selected to The Leukemia & Lymphoma Society’s Therapy Acceleration Program and Receives $3 Million Strategic Equity Investment
Lund, Sweden – January 17, 2023 – BioInvent International AB (“BioInvent”) (Nasdaq Stockholm: BINV), a biotech company focused on the discovery and de…
News
Insured Cancer Patients Continue to Face Barriers To Medically Necessary Treatment, New Report Warns
The new report published by The Leukemia & Lymphoma Society and Manatt Health offers concrete policy solutions.
Media resources
Email
Contact us for inquiries and interview requests.
Press Kit
Explore details for journalists and media outlets.
Brand Center
Access approved logos, guidelines, and other assets.